1. [BP.03.06] EFFECT OF COMBINED HORMONAL REPLACEMENT THERAPY ON THE ALDOSTERONE/RENIN RATIO IN POSTMENOPAUSAL WOMEN. (September 2017) Authors: Ahmed, A.; Gordon, R.D.; Ward, G.; Wolley, M.; Mcwhinney, B.; Ungerer, J.; Stowasser, M. Journal: Journal of hypertension Issue: Volume 35(2017)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. [PP.07.06] EFFECT OF MOXONIDINE ON THE ALDOSTERONE/RENIN RATIO CALCULATED BY BOTH PLASMA RENIN ACTIVITY AND DIRECT RENIN CONCENTRATION IN HEALTHY MALE VOLUNTEERS. (September 2017) Authors: Ahmed, A.; Gordon, R.D.; Ward, G.; Wolley, M.; Stowasser, M. Journal: Journal of hypertension Issue: Volume 35(2017)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Alcohol misuse—a national pandemic: an investigation to identify whether implementing an alcohol brief intervention service would benefit patients attending an oral and maxillofacial (OMFS) department. (April 2017) Authors: Wright, A.L.; Clark, A.S.E.; Ward, G.; Moodie, F.; Taylor, G.D.; Boyd, D.; Currie, W.J.R.; Hislop, W.S.; Halsnad, S.M. Journal: Public health Issue: Volume 145(2017) Page Start: 20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EP-1452: Safety & tolerability of radiotherapy dose escalation in cervical-upper thoracic oesophageal cancer. (April 2018) Authors: Jones, C.; Murray, P.; Goody, R.; Ward, G.; Casanova, N.; Hatfield, P.; Radhakrishna, G. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S789 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. EP-1813: Clinical implementation of an adaptive planning technique for lung VMAT radiotherapy. (April 2016) Authors: Naisbit, M.; Ward, G.; Lilley, J. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S850 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. EP-1954 The role of 4D cone beam CT and abdominal compression in motion management for Liver SABR. (April 2019) Authors: Nix, M.; Ward, G.; Goody, R.; Lilley, J.; Casanova, N.; Garratt, R.; Picken, K.; Al-Qaisieh, B. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S1065 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Lean in, don't step back: The views and experiences of patients and carers with severe mental illness and incurable physical conditions on palliative and end of life care. (3rd September 2021) Authors: Jerwood, J.; Ward, G.; Phimister, D.; Holliday, N.; Coad, J. Journal: Progress in palliative care Issue: Volume 29:Number 5(2021) Page Start: 255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Low SKP2 expression is predictive of sensitivity to an MDM2 antagonist in p53 wild-type AML. (October 2022) Authors: Kucia-Tran, J.; Bevan, L.; Chessari, G.; Fazal, L.; Ferrari, N.; Lyons, J.; Saini, H.; Wallis, N.; Ward, G.; Ahn, M. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P1278: ACTIVATION OF THE NECROPTOSIS PATHWAY PLAYS A ROLE IN SYNERGISM WITH COMBINATION OF THE IAP ANTAGONIST, TOLINAPANT AND HYPOMETHYLATING AGENTS (HMA) IN IN VITRO MODELS OF T-CELL LYMPHOMA (TCL). (23rd June 2022) Authors: Manavalan, J. S.; Pal, I.; Pursley, A.; Ward, G.; Smyth, T.; Sims, M.; Feith, D.; Loughran, T. P.; O'Connor, O. A.; Marchi, E. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P1293: COMBINING THE IAP ANTAGONIST, TOLINAPANT, WITH A DNA HYPOMETHYLATING AGENT ENHANCES ANTI-TUMOUR MECHANISMS IN PRECLINICAL MODELS OF T-CELL LYMPHOMA. (23rd June 2022) Authors: Sims, M.; Ward, G.; Zhang, Z.; Jueliger, S.; Davis, M.; Boxall, A.; Taylor, J.; Biondo, A.; Lyons, J.; Smyth, T. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗